Literature DB >> 23850951

Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.

Aggeliki Poulou1, Evangelia Voulgari, Georgia Vrioni, Vasiliki Koumaki, Grigorios Xidopoulos, Vasiliki Chatzipantazi, Fani Markou, Athanassios Tsakris.   

Abstract

Although numerous studies have documented outbreaks of carbapenem-resistant Klebsiella pneumoniae (CRKP) possessing various carbapenemases, reports on outbreaks due to CRKP possessing extended-spectrum β-lactamases (ESBLs) and/or AmpCs with porin lesions have been limited. Here, we describe an outbreak caused by an ertapenem-resistant, CTX-M-15-producing clonal K. pneumoniae strain expressing an OmpK36 porin variant. From May 2012 to November 2012, 37 ertapenem-resistant K. pneumoniae isolates phenotypically negative for carbapenemase production were recovered from 19 patients hospitalized in the intensive care unit of a Greek hospital. The isolates were either susceptible or intermediate to other carbapenems and resistant to all remaining β-lactams but cefotetan. Phenotypic and molecular analysis revealed the presence in all isolates of the blaCTX-M-15 gene on a conjugative 100-kb plasmid, disruption in the expression of the ompK35 gene, and the production of an Ompk36 porin variant. The index case was a patient admitted from another hospital. Active surveillance upon admission and on a weekly basis was immediately initiated; environmental samples were also periodically tested. Molecular typing showed that all clinical isolates as well as two ertapenem-resistant environmental K. pneumoniae isolates belonged to the same clonal type and were assigned to multilocus sequence typing (MLST) sequence type 101 (ST101). As all colonized/infected patients were hospitalized during overlapping periods, cross-infection was considered the main route for the dissemination of the outbreak strain. Despite reinforcement of infection control measures and active surveillance, the outbreak lasted approximately 7 months. Identification of hidden carriers upon admission and by screening on a weekly basis was found valuable for early recognition and subsequent successful management of the outbreak.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23850951      PMCID: PMC3811621          DOI: 10.1128/JCM.01244-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.

Authors:  Caterina Mammina; Celestino Bonura; Aurora Aleo; Teresa Fasciana; Tamara Brunelli; Giovanna Pesavento; Roberto Degl'Innocenti; Antonino Nastasi
Journal:  Int J Antimicrob Agents       Date:  2012-04-23       Impact factor: 5.283

Review 2.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.

Authors:  R Cantón; M Akóva; Y Carmeli; C G Giske; Y Glupczynski; M Gniadkowski; D M Livermore; V Miriagou; T Naas; G M Rossolini; Ø Samuelsen; H Seifert; N Woodford; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2012-05       Impact factor: 8.067

3.  Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.

Authors:  Yu-Kuo Tsai; Chang-Phone Fung; Jung-Chung Lin; Jiun-Han Chen; Feng-Yee Chang; Te-Li Chen; L Kristopher Siu
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures.

Authors:  A Robustillo Rodela; C Díaz-Agero Pérez; T Sanchez Sagrado; P Ruiz-Garbajosa; M J Pita López; V Monge
Journal:  Euro Surveill       Date:  2012-02-16

5.  Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.

Authors:  Eva Chudácková; Tamara Bergerová; Karel Fajfrlík; Dana Cervená; Pavla Urbásková; Joanna Empel; Marek Gniadkowski; Jaroslav Hrabák
Journal:  FEMS Microbiol Lett       Date:  2010-05-17       Impact factor: 2.742

6.  Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital.

Authors:  Jiunn-Jong Wu; Li-Rong Wang; Yi-Fang Liu; Hung-Mo Chen; Jing-Jou Yan
Journal:  Microb Drug Resist       Date:  2011-02-25       Impact factor: 3.431

7.  An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Authors:  Panagiota Giakkoupi; Costas C Papagiannitsis; Vivi Miriagou; Olga Pappa; Michalis Polemis; Kyriaki Tryfinopoulou; Leonidas S Tzouvelekis; Alkiviadis C Vatopoulos
Journal:  J Antimicrob Chemother       Date:  2011-05-04       Impact factor: 5.790

Review 8.  Carbapenem resistance in Enterobacteriaceae: here is the storm!

Authors:  Patrice Nordmann; Laurent Dortet; Laurent Poirel
Journal:  Trends Mol Med       Date:  2012-04-03       Impact factor: 11.951

9.  An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.

Authors:  Aurora García-Fernández; Vivi Miriagou; Costas C Papagiannitsis; Alessandra Giordano; Mario Venditti; Carlo Mancini; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

Review 10.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

View more
  17 in total

Review 1.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

Review 2.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.

Authors:  Jesús Oteo; María Pérez-Vázquez; Verónica Bautista; Adriana Ortega; Pilar Zamarrón; David Saez; Sara Fernández-Romero; Noelia Lara; Raquel Ramiro; Belén Aracil; José Campos
Journal:  J Antimicrob Chemother       Date:  2016-08-15       Impact factor: 5.790

5.  Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.

Authors:  Scott R Evans; Andrea M Hujer; Hongyu Jiang; Kristine M Hujer; Thomas Hall; Christine Marzan; Michael R Jacobs; Rangarajan Sampath; David J Ecker; Claudia Manca; Kalyan Chavda; Pan Zhang; Helen Fernandez; Liang Chen; Jose R Mediavilla; Carol B Hill; Federico Perez; Angela M Caliendo; Vance G Fowler; Henry F Chambers; Barry N Kreiswirth; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2015-09-25       Impact factor: 9.079

6.  Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.

Authors:  Maria S Ramirez; German M Traglia; David L Lin; Tung Tran; Marcelo E Tolmasky
Journal:  Microbiol Spectr       Date:  2014

7.  An outbreak of ertapenem-resistant, carbapenemase-negative and porin-deficient ESBL-producing Klebsiella pneumoniae complex.

Authors:  Mihaela Matovina; Maja Abram; Davorka Repac-Antić; Samira Knežević; Marina Bubonja-Šonje
Journal:  Germs       Date:  2021-06-02

8.  Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.

Authors:  Aggeliki Poulou; Evgenia Grivakou; Georgia Vrioni; Vassiliki Koumaki; Theodoros Pittaras; Spyros Pournaras; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

Review 9.  Next-generation approaches to understand and combat the antibiotic resistome.

Authors:  Terence S Crofts; Andrew J Gasparrini; Gautam Dantas
Journal:  Nat Rev Microbiol       Date:  2017-04-10       Impact factor: 60.633

Review 10.  Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes.

Authors:  Boahemaa Adu-Oppong; Andrew J Gasparrini; Gautam Dantas
Journal:  Ann N Y Acad Sci       Date:  2016-10-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.